Sign in or Register
  |  

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

Basal-Cell Carcinoma (BCC)

Fig.1 Basal-cell carcinoma

Basal-cell carcinoma (BCC), also named as basal-cell cancer, is the most typical type of skin cancer. It often displays as a painless raised area of skin, that may be shiny with small blood vessels running over it or it may display as a raised area with ulceration. Basal-cell cancer grows slowly and can be harmful to the tissue around it but is not commonly to spread to distant areas or lead to death. Around 60% of basal-cell carcinomas occur on sun-exposed areas of the body. About 30% occurs on areas of the body that are not exposed to sunlight, stressing the genetic susceptibility of basal-cell cancer. Morpheaform or Infiltrative basal-cell cancers can display as the scar tissue or skin thickening, thus making diagnosis difficult without using a skin biopsy and tactile sensation. Ki67 is a biologic marker of basal cell carcinoma.

Hot Products: